プログラム テーマ 中咽頭 (13 : : 45) 1 13 : : 35 : CQ1 : HPV CQ2 : : : 40 : CQ3 : CQ4 : : : 45 : CQ5 :

Size: px
Start display at page:

Download "プログラム テーマ 中咽頭 (13 : : 45) 1 13 : : 35 : CQ1 : HPV CQ2 : : : 40 : CQ3 : CQ4 : : : 45 : CQ5 :"

Transcription

1 会長挨拶 HPV ,124 CQ 7 HPV 3 CRT CQ 24 舘田勝 1

2 プログラム テーマ 中咽頭 (13 : : 45) 1 13 : : 35 : CQ1 : HPV CQ2 : : : 40 : CQ3 : CQ4 : : : 45 : CQ5 : 9. CQ6 : CQ7 : CRT

3 17 : : 00 : : 楯谷一郎 : 3

4 : TEL : m TEL :

5 1. 当科における中咽頭癌症例の臨床的検討 TNM T1 T2 T3 T4a T4b N0 N1 N2a N2b N2c N M0 I II III IVa IVb HPV p DNA % 5 75% HPV 21 51% 5 94% 56% 5 5 I 100% II 100% III 89% IVa 69% IVb 37% 5

6 2. 札幌医科大学における中咽頭癌の治療成績の検討 : : OS CSS CSS p16 SCC 49 TN T12 vs T34 N vs + p16 OS CSS p16 : Stage I 5 II 10 III 4 IVA 45 IVB 12 IVC 1 T1 10 T2 30 T3 11 T4a 16 T4b 10 N0 21 N1 5 N2a 4 N2b 33 N2c 11 N3 3 M0 76 M1 1 p BSC OS % 3 5 CSS 70.3% 61.8% CSS 59.0% OS CSS TN T12 vs T34 N vs + p16 p % 83.3% : p16 TN p16 6

7 3. 北海道大学病院における中咽頭扁平上皮癌症例の検討 % % % I 20 10% II 28 13% III 19 9% IVA % IVB 17 7% IVC IV - CRT 82 BRT 7 RADPLAT : 77.4% 0 - I : 80.4% II : 83.8% III : 100% IV : 72.6% : 52% I 57% II 56% III 52% IV : 49% n=65 ; : 65% I 72% II 79% III 73% IV : 54% n=156 ; 15 HPV PCR HPV % HPV % HPV % HPV HPV 8 5 HPV 92.8% 65.4% HPV 7

8 4. 当科における中咽頭扁平上皮癌症例の治療成績 I :3 II :4 III :5 IVA : 26 IVB :4 IVC :1 T T1 : 6 T2 : 21 T3 : 7 T4a : 7 T4b : 2 N N0 : 8 N1 : 5 N2a : 1 N2b : 15 N2c : 11 N3 : 3 M TPF 15 BRT 7 RT 3 3 CDDP CRT 2 BSC 2 p % % I % II % III % IVA % IVB % IVC 3 5 0% I % II % III % IVA % IVB % IVC 3 5 0% 8

9 5. 当科における中咽頭癌症例の検討 % % % % 4 9.5% T T1 : T2 : T3 : T4a : T4b= 4 9.5% : % : % : 3 7.1% : 0 N N0 : N1 : N2a : N2b : N2c : N % : % : 1 2.4% : % : 4 9.5% : 2 4.8% Stage Stage I : II : III : IVA : IVB=1 2.4% : % : % : % : 2 4.8% % 3 7.1% % Best Supportive Care Stage II : 2 Stage IVa : 2 Stage IVb : 1 3 /5 Stage II : 77.1 / 77.1% Stage III : 88.9/ 71.1% Stage IVA : 66.7/66.7% Stage I Stage IVB

10 6. 福島県立医科大学における中咽頭癌症例の臨床的検討 HPV HPV Stage I 9 Stage II 9 Stage III 8 Stage IVA 27 Stage IVB 4 Stage IVC 8 TNM T : T1 11 T2 28 T3 7 T4a 13 T4b 6 N : N0 23 N1 6 N2a 3 N2b 12 N2c 17 N3 4 M : M0 57 M CRT 48 BSC 3 Kaplan - Meier % % % % Stage 5 StageI 71.1% Stage II 100% Stage III 100% Stage IVA 69.1% Stage IVB 25.0% 3 Stage IVC 20.0% 5 Stage I 100% Stage II 100% Stage III 100% Stage IVA 76.0% Stage IVB 25.0% 3 Stage IVC 20.0% Stage IVB p16 10

11 7. 秋田大学における中咽頭癌症例の検討 : 64.6 : : : : 36.2 : 27 : 25 : 61 :8 : 12 0 :3 I :1 II :7 III : 13 IVA : 65 IVB : 13 IVC :4 T Tis : 3 T1 : 4 T2 : 38 T3 : 29 T4a : 21 T4b : 11 N N0 : 15 N1 : 11 N2a : 1 N2b : 39 N2c : 32 N3 : 8 M1 4 0 I II III IV Gy 2014 : 21 : 22 : 58 BSC : 1 : 10 : 10 : 86 Kaplan - Meier : 100% 100% I : 100% 100% II : 100% 100% III : 75% 75% IVA : 58.8% 62.2% IVB : 45.8% 45.8% IVC : 0% 0% : 100% 100% I : 100% 100% II : 75% 100% III : 62.5% 75% IVA : 44.4% 51.3% IVB : 15.3% 15.3% IVC : 0% 0% 11

12 8. 当院における中咽頭癌症例についての検討 I :3 II :6 III :4 IVA : 25 IVB :2 IVC :1 T T1 : 8 T2 : 23 T3 : 1 T4a : 12 T4b : 0 N N0 : 11 N1 : 5 N2a : 5 N2b : 14 N2c :7 N3 : 2 M BSC % I : 100% 100% II : 80% 80% III : 100% 100% IVA : 60% 60% % I : 100% 100% II : 100% 100% III : 100% 100% IVA : 68% 68% 0 p

13 9. 当科における中咽頭癌症例の検討 % % % % % % % I % II % III % IVa % IVb % IVc 3 2.0% T Tis 5 3.3% T % T % T % T4a % T4b 5 3.3% N N % N % N2a 2 1.3% N2b % N2c % N % % ELPS % 14 BSC 7 4.6% % 56.8% % 61.7% % 59.4% % 54.4% Stage 3 5 Stage % 66.7% Stage I 87.5% 87.5% Stage II 93.3% 72.0% Stage III 76.5% 68.9% Stage IVa 54.7% 49.8% Stage IVb 22.2% 22.2% Stage IVc 0.0% 0.0% p % % p % 83.1% p % 71.3% 13

14 10. 当科における中咽頭癌症例の臨床的検討 % p16 5 p p % % 0 100% I 100% II 83.3% III 71.1% IV 59.1% % 73.9% 80.0% 46.9% p16 5 p16 100% p % % 100% p16 QOL 14

15 11. 当科における中咽頭癌症例の検討 : 29 : 77 :7 : 10 Stage I : 13 Stage II : 16 Stage III : 16 Stage IVA : 52 Stage IVB : 18 Stage IVC : 8 TNM Tis : 0 T1 : 19 T2 : 48 T3 : 23 T4a : 18 T4b : 15 N0 : 37 N1 : 12 N2a : 2 N2b : 44 N2c : 23 N3 : 5 M0 : 114 M1 : 9 Kaplan - Meier 3 5 Stage I : 90.0% 60.0% Stage II : 67.7% 67.7% Stage III : 77.9% 77.9% Stage IVA : 70.4% 63.8% Stage IVB : 46.7% 46.7% Stage IVC : 12.5% 12.5% 3 5 Stage I : 90.0% 60.0% Stage II : 74.1% 74.1% Stage III : 85.7% 85.7% Stage IVA : 70.4% 63.8% Stage IVB : 46.7% 46.7% Stage IVC : 12.5% 12.5% : 49 : 70 BSC : 4 : 16 : 107 p16 : 27 : 37 : 59 15

16 12. 中咽頭癌 140 例の臨床統計 NOS : I 13 II 12 III 15 IVA 78 IVB 13 IVC % IVA TNM Tis 0 T1 29 T2 44 T3 23 T4a 32 T4b 7 N0 34 N1 11 N2a 5 N2b 53 N2c 24 N3 8 M0 131 M1 4 p % BSC % CDDP 36 TPF 21 Cetuximab 4 CDDP % 57.8% % 66.4% 3 5 I : 70.0% 58.3% II : 90.9% 90.9% III : 66.7% 59.3% IVA : 64.7% 57.3% IVB : 52.7% 42.2% IVC : 25.0% 25.0% 3 5 I : 90.0% 90.0% II : 100% 100% III : 73.3% 73.3% IVA : 68.5% 62.9% IVB : 52.7% 42.2% IVC : 25.0% 25.0% 16

17 I II III IVA IVB IVC Tis T T T T T4a T4b N N N N2a N2b N2c N M M I II OS III IVA IVB X IVC X I II OS III IVA IVB X 15.3 X IVC X I II DSS III IVA IVB X IVC X I II DSS III IVA IVB X 15.3 X IVC X p16 BSC

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2) (1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46

More information

i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii

More information

i

i 14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7

More information

第1部 一般的コメント

第1部 一般的コメント (( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12

More information

表1票4.qx4

表1票4.qx4 iii iv v 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 22 23 10 11 24 25 26 27 10 56 28 11 29 30 12 13 14 15 16 17 18 19 2010 2111 22 23 2412 2513 14 31 17 32 18 33 19 34 20 35 21 36 24 37 25 38 2614

More information

第1章 国民年金における無年金

第1章 国民年金における無年金 1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20

More information

I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................

More information

20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472

More information

- 2 -

- 2 - - 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -

More information

2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1

2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1 1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4

More information

1 (1) (2)

1 (1) (2) 1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)

More information

provider_020524_2.PDF

provider_020524_2.PDF 1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24

More information

「産業上利用することができる発明」の審査の運用指針(案)

「産業上利用することができる発明」の審査の運用指針(案) 1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)

More information

i ii iii iv v vi vii ( ー ー ) ( ) ( ) ( ) ( ) ー ( ) ( ) ー ー ( ) ( ) ( ) ( ) ( ) 13 202 24122783 3622316 (1) (2) (3) (4) 2483 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 11 11 2483 13

More information

178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21

178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 I 178 II 180 III ( ) 181 IV 183 V 185 VI 186 178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 4 10 (

More information

1-1 - 2 3-2 - - 3 - i - 4 - ii - 5 - c - 6 - 4 1-7 - 2 1-8 - 2-9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - 3-18 - - 19 - - 20 - - 21 - - 22 - - 23 - iii i - 24 - - 25 - - 26 - 4-27 - 5

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81 9 CQ 1 80 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81 CQ 2 82 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 83 84 CQ 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 85 CQ 4

More information

untitled

untitled i ii iii iv v 43 43 vi 43 vii T+1 T+2 1 viii 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 a) ( ) b) ( ) 51

More information

AccessflÌfl—−ÇŠš1

AccessflÌfl—−ÇŠš1 ACCESS ACCESS i ii ACCESS iii iv ACCESS v vi ACCESS CONTENTS ACCESS CONTENTS ACCESS 1 ACCESS 1 2 ACCESS 3 1 4 ACCESS 5 1 6 ACCESS 7 1 8 9 ACCESS 10 1 ACCESS 11 1 12 ACCESS 13 1 14 ACCESS 15 1 v 16 ACCESS

More information

活用ガイド (ソフトウェア編)

活用ガイド (ソフトウェア編) ii iii iv NEC Corporation 1998 v vi PA RT 1 vii PA RT 2 viii PA RT 3 PA RT 4 ix P A R T 1 2 3 1 4 5 1 1 2 1 2 3 4 6 1 2 3 4 5 7 1 6 7 8 1 9 1 10 1 2 3 4 5 6 7 8 9 10 11 11 1 12 12 1 13 1 1 14 2 3 4 5 1

More information

2

2 1 2 3 4 5 6 7 8 9 10 I II III 11 IV 12 V 13 VI VII 14 VIII. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 _ 33 _ 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 VII 51 52 53 54 55 56 57 58 59

More information

262014 3 1 1 6 3 2 198810 2/ 198810 2 1 3 4 http://www.pref.hiroshima.lg.jp/site/monjokan/ 1... 1... 1... 2... 2... 4... 5... 9... 9... 10... 10... 10... 10... 13 2... 13 3... 15... 15... 15... 16 4...

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 () - 1 - - 2 - - 3 - - 4 - - 5 - 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

More information

食道がん化学放射線療法後のsalvage手術

食道がん化学放射線療法後のsalvage手術 2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573

More information

- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...

- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8... 取 扱 説 明 書 - - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...9...11 - - - - - - - - - - - - - - - - -

More information

r e -

r e - A A e r t y u i o!0 r e - i i i i i i i yi i y y i r e r e euo!0 u eo!0 e e o u!0 o t r e e e er e r e r C D A B C A i A ii A iii A B D A iv - e r r e AA ia iia iii A iva - SPECIAL GEAR & ACCESSORIES

More information

ito.dvi

ito.dvi 1 2 1006 214 542 160 120 160 1 1916 49 1710 55 1716 1 2 1995 1 2 3 4 2 3 1950 1973 1969 1989 1 4 3 3.1 3.1.1 1989 2 3.1.2 214 542 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

More information

86 7 I ( 13 ) II ( )

86 7 I ( 13 ) II ( ) 10 I 86 II 86 III 89 IV 92 V 2001 93 VI 95 86 7 I 2001 6 12 10 2001 ( 13 ) 10 66 2000 2001 4 100 1 3000 II 1988 1990 1991 ( ) 500 1994 2 87 1 1994 2 1000 1000 1000 2 1994 12 21 1000 700 5 800 ( 97 ) 1000

More information

入門ガイド

入門ガイド ii iii iv NEC Corporation 1998 v P A R 1 P A R 2 P A R 3 T T T vi P A R T 4 P A R T 5 P A R T 6 P A R T 7 vii 1P A R T 1 2 2 1 3 1 4 1 1 5 2 3 6 4 1 7 1 2 3 8 1 1 2 3 9 1 2 10 1 1 2 11 3 12 1 2 1 3 4 13

More information

SC-85X2取説

SC-85X2取説 I II III IV V VI .................. VII VIII IX X 1-1 1-2 1-3 1-4 ( ) 1-5 1-6 2-1 2-2 3-1 3-2 3-3 8 3-4 3-5 3-6 3-7 ) ) - - 3-8 3-9 4-1 4-2 4-3 4-4 4-5 4-6 5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9 5-10 5-11

More information

<4D6963726F736F667420506F776572506F696E74202D208376838C835B83938365815B835683878393312E707074205B8CDD8AB78382815B83685D>

<4D6963726F736F667420506F776572506F696E74202D208376838C835B83938365815B835683878393312E707074205B8CDD8AB78382815B83685D> i i vi ii iii iv v vi vii viii ix 2 3 4 5 6 7 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

More information

2 1 2 3 27 2 6 2 5 19 50 1 2

2 1 2 3 27 2 6 2 5 19 50 1 2 1 2 1 2 3 27 2 6 2 5 19 50 1 2 2 17 1 5 6 5 6 3 5 5 20 5 5 5 4 1 5 18 18 6 6 7 8 TA 1 2 9 36 36 19 36 1 2 3 4 9 5 10 10 11 2 27 12 17 13 6 30 16 15 14 15 16 17 18 19 28 34 20 50 50 5 6 3 21 40 1 22 23

More information

1 10 1113 14 1516 1719 20 21 22 2324 25 2627 i 2829 30 31 32 33 3437 38 3941 42 4344 4547 48 4950 5152 53 5455 ii 56 5758 59 6061 iii 1 2 3 4 5 6 7 8 9 10 PFI 30 20 10 PFI 11 12 13 14 15 10 11 16 (1) 17

More information

T T T T A 0 1 A 1 A P (A 1 ) = C 1 6 C 8C 3 = 15 8, P (A ) = C 6 C 1 8C 3 = 3 8 T 5 B P (A 1 B) = =

T T T T A 0 1 A 1 A P (A 1 ) = C 1 6 C 8C 3 = 15 8, P (A ) = C 6 C 1 8C 3 = 3 8 T 5 B P (A 1 B) = = 4 1.. 3. 4. 1. 1 3 4 5 6 1 3 4 5 6. 1 1 1 A B P (A B) = P (A) + P (B) P (C) = P (A) P (B) 3. 1 1 P (A) = 1 P (A) A A 4. A B P A (B) = n(a B) n(a) = P (A B) P (A) 50 015 016 018 1 4 5 8 8 3 T 1 3 1 T T

More information

untitled

untitled 23 12 10 12:55 ~ 18:45 KKR Tel0557-85-2000 FAX0557-85-6604 12:55~13:00 13:00~13:38 I 1) 13:00~13:12 2) 13:13~13:25 3) 13:26~13:38 13:39~14:17 II 4) 13:39~13:51 5) 13:52 ~ 14:04 6) 14:05 ~ 14:17 14:18 ~

More information

o 2o 3o 3 1. I o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o I 2o 3o 4o 5o 6o 7o 2197/ o 1o 1 1o

o 2o 3o 3 1. I o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o I 2o 3o 4o 5o 6o 7o 2197/ o 1o 1 1o 78 2 78... 2 22201011... 4... 9... 7... 29 1 1214 2 7 1 8 2 2 3 1 2 1o 2o 3o 3 1. I 1124 4o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o 72 1. I 2o 3o 4o 5o 6o 7o 2197/6 9. 9 8o 1o 1 1o 2o / 3o 4o 5o 6o

More information

印刷用一括

印刷用一括 I.... - 2 -...- 2 -...- 2 -...- 2 -...- 3 -...- 4 -...- 6 - II.... - 7 - III.... - 9 -...- 9 -...- 15 -...- 20 -...- 22 -...- 28 - IV.... - 33 -...- 33 -...- 33 -...- 70 -...- 85 -...- 106 - V.... - 122

More information

無印良品のスキンケア

無印良品のスキンケア 2 3 4 5 P.22 P.10 P.18 P.14 P.24 Na 6 7 P.10 P.22 P.14 P.18 P.24 8 9 1701172 1,400 1701189 1,000 1081267 1,600 1701257 2,600 1125923 450 1081250 1,800 1125916 650 1081144 1,800 1081229 1,500 Na 1701240

More information

4 13 6 7 6 13 9 19

4 13 6 7 6 13 9 19 13 9 4 13 6 7 6 13 9 19 139 173 i 1 1 2 1 3 2 4 2 5 1 3 6 4 7 5 8 6 9 6 Q&A Q1 QA 9 Q2 9 Q3 10 Q4 11 Q5 11 Q6 11 Q7 12 Q8 12 ii Q9 12 Q101 13 Q102 13 Q11 17 Q12 18 Q13 18 Q14 19 Q15 19 Q16 20 Q17 20 Q18

More information

SURF 200000300104 Sendai Urban Research Forum 1 1 1 4 5 5 5 5 6 8 8 13 17 18 20 20 23 29 35 35 35 35 36 36 37 37 39 40 44 44 45 45 49 51 52 54 60 52 63 69 69 70 71 72 73 70 70 70 71 71 72 74 78 86 102

More information

JA2008

JA2008 A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5

More information

(個別のテーマ) 放射線検査に関連した医療事故

(個別のテーマ) 放射線検査に関連した医療事故 - 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -

More information

(個別のテーマ) 薬剤に関連した医療事故

(個別のテーマ) 薬剤に関連した医療事故 - 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89

More information

EV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1

More information

これわかWord2010_第1部_100710.indd

これわかWord2010_第1部_100710.indd i 1 1 2 3 6 6 7 8 10 10 11 12 12 12 13 2 15 15 16 17 17 18 19 20 20 21 ii CONTENTS 25 26 26 28 28 29 30 30 31 32 35 35 35 36 37 40 42 44 44 45 46 49 50 50 51 iii 52 52 52 53 55 56 56 57 58 58 60 60 iv

More information

パワポカバー入稿用.indd

パワポカバー入稿用.indd i 1 1 2 2 3 3 4 4 4 5 7 8 8 9 9 10 11 13 14 15 16 17 19 ii CONTENTS 2 21 21 22 25 26 32 37 38 39 39 41 41 43 43 43 44 45 46 47 47 49 52 54 56 56 iii 57 59 62 64 64 66 67 68 71 72 72 73 74 74 77 79 81 84

More information

これでわかるAccess2010

これでわかるAccess2010 i 1 1 1 2 2 2 3 4 4 5 6 7 7 9 10 11 12 13 14 15 17 ii CONTENTS 2 19 19 20 23 24 25 25 26 29 29 31 31 33 35 36 36 39 39 41 44 45 46 48 iii 50 50 52 54 55 57 57 59 61 63 64 66 66 67 70 70 73 74 74 77 77

More information

訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書

訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書 1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....

More information

ÿþ

ÿþ I O 01 II O III IV 02 II O 03 II O III IV III IV 04 II O III IV III IV 05 II O III IV 06 III O 07 III O 08 III 09 O III O 10 IV O 11 IV O 12 V O 13 V O 14 V O 15 O ( - ) ( - ) 16 本 校 志 望 の 理 由 入 学 後 の

More information

平成18年版 男女共同参画白書

平成18年版 男女共同参画白書 i ii iii iv v vi vii viii ix 3 4 5 6 7 8 9 Column 10 11 12 13 14 15 Column 16 17 18 19 20 21 22 23 24 25 26 Column 27 28 29 30 Column 31 32 33 34 35 36 Column 37 Column 38 39 40 Column 41 42 43 44 45

More information

untitled

untitled i ii (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (2) (3) (1) (2) (3) (1) (1) (1) (1) (2) (1) (3) (1) (2) (1) (3) (1) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3)

More information

23 15961615 1659 1657 14 1701 1711 1715 11 15 22 15 35 18 22 35 23 17 17 106 1.25 21 27 12 17 420,845 23 32 58.7 32 17 11.4 71.3 17.3 32 13.3 66.4 20.3 17 10,657 k 23 20 12 17 23 17 490,708 420,845 23

More information

平成18年度「商品先物取引に関する実態調査」報告書

平成18年度「商品先物取引に関する実態調査」報告書 ... 1.... 5-1.... 6-2.... 9-3.... 10-4.... 12-5.... 13-6.... 15-7.... 16-8.... 17-9.... 20-10.... 22-11.... 24-12.... 27-13... 29-14.... 32-15... 37-16.... 39-17.... 41-18... 43-19... 45.... 49-1... 50-2...

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ( ) 24 25 26 27 28 29 30 ( ) ( ) ( ) 31 32 ( ) ( ) 33 34 35 36 37 38 39 40 41 42 43 44 ) i ii i ii 45 46 47 2 48 49 50 51 52 53 54 55 56 57 58

More information

エクセルカバー入稿用.indd

エクセルカバー入稿用.indd i 1 1 2 3 5 5 6 7 7 8 9 9 10 11 11 11 12 2 13 13 14 15 15 16 17 17 ii CONTENTS 18 18 21 22 22 24 25 26 27 27 28 29 30 31 32 36 37 40 40 42 43 44 44 46 47 48 iii 48 50 51 52 54 55 59 61 62 64 65 66 67 68

More information

State Committee of Russian Federation on Statistics 1 2 12 State Committee of Russian Federation on Statistics 53

State Committee of Russian Federation on Statistics 1 2 12 State Committee of Russian Federation on Statistics 53 I State Committee of Russian Federation on Statistics 52 State Committee of Russian Federation on Statistics 1 2 12 State Committee of Russian Federation on Statistics 53 State Committee of Russian Federation

More information

1 II III IV V 1 2 3 4 5 56 56 6 7 8 9 10 11 1988(S.63) 12 13 14 15 1988(S.63) 16 1988(S.63) 17 1988(S.63) 1988(S.63) 18 19 20 21 22 23 24 25 26 27 28 18-III 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

More information

16 16 16 1 16 2 16 3 24 4 24 5 25 6 33 7 33 33 1 33 2 34 3 34 34 34 34 34 34 4 34-1 - 5 34 34 34 1 34 34 35 36 36 2 38 38 41 46 47 48 1 48 48 48-2 - 49 50 51 2 52 52 53 53 1 54 2 54 54 54 56 57 57 58 59

More information